Analytical Validation of a Clinical Grade Prognostic and Classification...
This is the first study of which we are aware to describe the analytical validation (AV) of clinical grade artificial intelli [...]
NCCN 2024 Guidelines Endorse Novel Prostate Test for Precision...
Rashid Sayyid and Zach Klaassen discuss the 2024 updates to the NCCN Prostate Cancer Guidelines, highlighting the emergence o [...]
ArteraAI and Movember Announce New Relationship
ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, today anno [...]
ASCO 2024 Annual Meeting
Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making [...]
AUA 2024 Annual Meeting
The Annual Meeting, in its 119th year, is the largest gathering of urologists in the world, providing unparalleled access to [...]
ArteraAI Prostate Test Included in NCCN Guidelines
The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer have included the ArteraAI [...]
ArteraAI Included in the 2024 NCCN Guidelines® for Prostate...
ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced [...]
Here’s how AI will drive health care to meet...
The rapid transformation of the health care landscape is undeniable. It is marked not only by groundbreaking technologies and [...]